‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal

‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal
Rewind to 2013. Ebos’s chief executive, Mark Waller (right), and Symbion’s chief executive, Patrick Davies, come together to mark a $1.1b transaction. (Image: NZME)
Rebecca Stevenson
In 2013, listed health and animal care company Ebos swallowed a giant. In June of that year, Ebos shareholders overwhelmingly voted for a $1.1 billion acquisition of pharmaceutical company Symbion, or Zuellig Healthcare Holdings Australia. This deal gave rise to a tagline Ebos still references today, as the largest diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It made Ebos then the third-largest listed company on the NZX, and a dual listing on the ASX followed la...

More Markets

Infratil and Ebos help drive NZ stocks higher
Markets Market Close

Infratil and Ebos help drive NZ stocks higher

Infrastructure investor helped the sharemarket end the week on a positive note.

Tom Raynel 25 Jul 2025
Bathurst fails to strike-out Talley's claims
Markets

Bathurst fails to strike-out Talley's claims

Talley's is alleging Companies Act breaches by its coal JV partner.

Pattrick Smellie 25 Jul 2025
New CFO for KMD Brands
Markets

New CFO for KMD Brands

Carla Webb-Sear has been appointed group chief financial officer for KMD Brands.She will join the group executive team on Aug 4 and report to Brent Scrimshaw, group chief executive and managing director.She joins KMD Brands from Qantas, where she was chief financial and strategy...

Staff reporters 25 Jul 2025
The fund riding a surge of golden visa cash
Markets

The fund riding a surge of golden visa cash

Punakaiki has raised more in a few months from visa applicants than all of 2025.